These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 23962712)
1. Urinary inositol phosphoglycan-P type: near patient test to detect preeclampsia prior to clinical onset of the disease. A study on 416 pregnant Mauritian women. Dawonauth L; Rademacher L; L'Omelette AD; Jankee S; Lee Kwai Yan MY; Jeeawoody RB; Rademacher TW J Reprod Immunol; 2014 Mar; 101-102():148-152. PubMed ID: 23962712 [TBL] [Abstract][Full Text] [Related]
2. Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder. Paine MA; Scioscia M; Williams PJ; Gumaa K; Rodeck CH; Rademacher TW Hypertens Pregnancy; 2010; 29(4):375-84. PubMed ID: 20701477 [TBL] [Abstract][Full Text] [Related]
3. New insights into early and late onset subgroups of preeclampsia from longitudinal versus cross-sectional analysis of urinary inositol-phosphoglycan P-Type. L'Omelette AD; Dawonauth L; Rademacher L; Robillard PY; Scioscia M; Jankee S; Lee Kwai Yan MY; Razgia JB; Rademacher TW J Reprod Immunol; 2018 Feb; 125():64-71. PubMed ID: 29253795 [TBL] [Abstract][Full Text] [Related]
4. Inositol phosphoglycan P-type in preeclampsia: a novel marker? Williams PJ; Gumaa K; Scioscia M; Redman CW; Rademacher TW Hypertension; 2007 Jan; 49(1):84-9. PubMed ID: 17116762 [TBL] [Abstract][Full Text] [Related]
5. Inositol phosphoglycan P-type in infants of preeclamptic mothers. Scioscia M; Robillard PY; Hall DR; Rademacher LH; Williams PJ; Rademacher TW J Matern Fetal Neonatal Med; 2012 Feb; 25(2):193-5. PubMed ID: 21401313 [TBL] [Abstract][Full Text] [Related]
6. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442 [TBL] [Abstract][Full Text] [Related]
7. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. Scioscia M; Gumaa K; Selvaggi LE; Rodeck CH; Rademacher TW J Perinat Med; 2009; 37(5):469-71. PubMed ID: 19492925 [TBL] [Abstract][Full Text] [Related]
8. A prospective cohort study on the clinical utility of second trimester mean arterial blood pressure in the prediction of late-onset preeclampsia among Nigerian women. Udenze IC; Arikawe AP; Makwe CC; Olowoselu OF Niger J Clin Pract; 2017 Jun; 20(6):741-745. PubMed ID: 28656930 [TBL] [Abstract][Full Text] [Related]
9. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Scioscia M; Kunjara S; Gumaa K; Gomez Galan AM; McLean P; Rodeck CH; Rademacher TW Gynecol Obstet Invest; 2007; 64(4):217-23. PubMed ID: 17664885 [TBL] [Abstract][Full Text] [Related]
10. The usefulness of CYFRA 21-1 to diagnose and predict preeclampsia: a nested case-control study. Kuessel L; Zeisler H; Ristl R; Binder J; Pateisky P; Schmid M; Marschalek J; Perkmann T; Haslacher H; Husslein H BMC Pregnancy Childbirth; 2016 Nov; 16(1):339. PubMed ID: 27809797 [TBL] [Abstract][Full Text] [Related]
11. Possible involvement of inositol phosphoglycan-P in human parturition. Paine MA; Rodeck CH; Williams PJ; Rademacher TW J Reprod Immunol; 2003 Aug; 59(2):267-75. PubMed ID: 12896828 [TBL] [Abstract][Full Text] [Related]
12. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia. Paine MA; Scioscia M; Gumaa KA; Rodeck CH; Rademacher TW J Reprod Immunol; 2006 Apr; 69(2):165-79. PubMed ID: 16384607 [TBL] [Abstract][Full Text] [Related]
13. Exploring strengths and limits of urinary D-chiro inositol phosphoglycans (IPG-P) as a screening test for preeclampsia: A systematic review and meta-analysis. Scioscia M; Noventa M; Cavallin F; Straface G; Pontrelli G; Fattizzi N; Libera M; Rademacher TW; Robillard PY J Reprod Immunol; 2019 Sep; 134-135():21-27. PubMed ID: 31382126 [TBL] [Abstract][Full Text] [Related]
14. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio. Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826 [TBL] [Abstract][Full Text] [Related]
15. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies. Scioscia M; Gumaa K; Whitten M; Selvaggi LE; Rodeck CH; Rademacher TW J Reprod Immunol; 2007 Dec; 76(1-2):85-90. PubMed ID: 17493685 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia. Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758 [TBL] [Abstract][Full Text] [Related]
18. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension. Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357 [TBL] [Abstract][Full Text] [Related]
19. Inositol phosphoglycans and preeclampsia: from bench to bedside. Scioscia M; Williams PJ; Gumaa K; Fratelli N; Zorzi C; Rademacher TW J Reprod Immunol; 2011 May; 89(2):173-7. PubMed ID: 21549431 [TBL] [Abstract][Full Text] [Related]
20. Elevation of urinary adipsin in preeclampsia: correlation with urine protein concentration and the potential use for a rapid diagnostic test. Wang T; Zhou R; Gao L; Wang Y; Song C; Gong Y; Jia J; Xiong W; Dai L; Zhang L; Hu H Hypertension; 2014 Oct; 64(4):846-51. PubMed ID: 24958499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]